Summary by Moomoo AI
On December 3, 2024, Fossil Pharmaceuticals announced that the loan term of its holding subsidiary, Puyun Health, would be extended by 12 months to December 4, 2025. The loans involved in this extension amounted to RMB6,550 million and were provided by Fossil Health, Ningbo Technology and Fossil High Technology, respectively, on a per shareholding ratio. The borrowing portion of Fossil Health and Ningbo Fintech is within the range approved by the 2023 Annual General Meeting, while the borrowing portion of Fossil Hi-Tech was provided with related financial assistance under the Listing Rules of the Securities and Exchange, but did not meet the Board's approval criteria.Forumyun Health was established in May 2021, mainly concerned with the R&D and sales of health management products and services...Show More